Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis
Open Access
- 1 August 2015
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 175 (8) , 1301-1309
Abstract
Allergic rhinoconjunctivitis is a common condition, affecting 5% to 40% of the general population, and there is evidence that its prevalence is increasing.1-3 To our knowledge, allergen-specific immunotherapy is the only current treatment that modifies the disease process. Allergen-specific immunotherapy for the treatment of allergic respiratory diseases has traditionally been administered by subcutaneous injections. Subcutaneous immunotherapy (SCIT) has proven efficacy in treating allergic rhinitis, but it requires regular injections at a physician’s office and carries the risk of potentially serious adverse events.4 The favorable safety profile and convenience of sublingual immunotherapy (SLIT) are likely factors for its widespread use in Europe, where it is now the preferred route of administration of allergen-specific immunotherapy and was licensed as a drug on September 26, 2009 (Grazax; Alk-Abellò and Oralair; Stallergenes).5Keywords
This publication has 42 references indexed in Scilit:
- Sublingual immunotherapy: World Allergy Organization position paper 2013 updateWorld Allergy Organization Journal, 2014
- Characterizing Rhinitis SubtypesAmerican Journal of Rhinology & Allergy, 2013
- Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A meta-analysis–based comparisonJournal of Allergy and Clinical Immunology, 2012
- Specific Allergy Immunotherapy for Allergic Rhinitis: Subcutaneous and SublingualImmunology and Allergy Clinics of North America, 2011
- Allergen-specific immunotherapy for respiratory allergies: From meta-analysis to registration and beyondJournal of Allergy and Clinical Immunology, 2011
- Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A systematic review and meta-analysisJournal of Allergy and Clinical Immunology, 2010
- Management of allergic rhinitisThe Lancet, 2008
- Sublingual immunotherapy: A comprehensive reviewJournal of Allergy and Clinical Immunology, 2006
- Long-Term Clinical Efficacy of Grass-Pollen ImmunotherapyNew England Journal of Medicine, 1999
- Sublingual‐swallow immunotherapy (SLIT) with a standardized five‐grass‐pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitisAllergy, 1999